209 In the index

Vesugen VESU

A Russian 'bioregulator' product marketed for blood-vessel and immune support. Its evidence base is limited to Russian-language research without independent confirmation.

Also known as KED peptide

Effects Longevity

Routes Subcutaneous

Legal status Research chemical

WADA Not listed

Reported dosing

Limited data

What has been reported in the literature and by users. This is a record of what is done, not a recommendation.

Typical dose Not established

Reported range Manufacturer-suggested: 1-2 capsules/day for 10-30 days

Route Oral (sublingual/buccal per manufacturer)

Frequency Once or twice daily

Duration 10-30 day course, per manufacturer

A Russian 'bioregulator' peptide product marketed for blood-vessel and immune support; evidence limited to Russian-language literature without independent confirmation.

Where this comes from Russian-language studies/manufacturer literature

Human data for this compound is limited. Read the figures above as a record of reported use rather than established dosing.